Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Vitae Pharmaceuticals presents 11beta-HSD1 inhibitors for obesity therapy

Dec. 21, 2009

Takeda claims glucokinase activators for the treatment of diabetes

Dec. 21, 2009

Taspoglutide meets primary endpoints in head-to-head phase III studies

Dec. 18, 2009

Auxilium reports topline phase IIb results of Xiaflex in Peyronie's disease

Dec. 18, 2009

Solvay presents novel CB1 receptor antagonists for obesity therapy

Dec. 18, 2009

Vitae Pharmaceuticals describes novel antidiabetic compounds

Dec. 18, 2009

DMC recommends continuation of two phase III trials of salmon calcitonin in osteoporosis

Dec. 18, 2009

Once-weekly exenatide superior to Byetta in type 2 diabetes patients

Dec. 17, 2009

Columbia University identifies VMAT2 ligands for the treatment of diabetes

Dec. 17, 2009

Novel TGR5 receptor agonists identified by AstraZeneca for type 2 diabetes treatment

Dec. 17, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...